¼¼°èÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀå : Medtech 360
Hyaluronic Acid Viscosupplementation | Medtech 360 | Market Insights | Global
»óǰÄÚµå : 1593161
¸®¼­Ä¡»ç : Clarivate
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 10,388 £Ü 14,667,000
Web Access and PDF Download (Corporate use license) help
µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½º ÀÔ´Ï´Ù. À̸ÞÀÏ·Î ¸µÅ©¿Í ºñ¹Ð¹øÈ£¸¦ º¸³» µå¸³´Ï´Ù. ÀÎÅÍ³Ý ¿¬°á·Î ¿­¶÷ÀÌ °¡´ÉÇϰí PDF º¸°í¼­ ´Ù¿î·Îµå°¡ °¡´ÉÇÕ´Ï´Ù. ÀμⰡ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â PDF ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°í·ÉÈ­ ¹× º¯Çü¼º °üÀýÁõ ȯÀÚ Áõ°¡¿Í °°Àº À¯¸®ÇÑ Àα¸Åë°è, ȯÀÚ ÀÇ½Ä Çâ»ó, ÀÇ»ç ±³À° °³¼±, ±â¾÷ÀÇ È¿°úÀûÀÎ ¸¶ÄÉÆÃ È°µ¿ ¹× Áö¼ÓÀûÀÎ Á¦Ç° Çõ½ÅÀº È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀåÀÇ ¿Ï¸¸ÇÑ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ´ëü Ä¡·á°¡ º¸±ÞµÇ°í ÀÖÁö¸¸, º¯Çü¼º °üÀýÁõ¿¡ ¼ö¹ÝµÇ´Â ÅëÁõ °æ°¨¿¡ À־ÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸ÃæÀÇ À¯È¿¼ºÀ» ÁöÁöÇÏ´Â »õ·Î¿î ÀÓ»óÀû Áõ°Å°¡ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ Àü¸ÁÀÔ´Ï´Ù. ¶ÇÇÑ ³ôÀº °¡°ÝÀÇ 1ȸ ÁÖ»ç Á¦Ç°Àº ±× Æí¸®¼º ¶§¹®¿¡ ¿¹Ãø ±â°£¿¡µµ °è¼Ó º¸±ÞµÉ Àü¸ÁÀÔ´Ï´Ù. ¹Ý¸é 3ȸ ÁÖ»ç Á¦Ç°À̳ª 5ȸ ÁÖ»ç Á¦Ç°Àº Á¦Ç°¿¡ ´ëÇÑ Á¢±Ù, ºñ¿ë, »óȯÀÇ Â÷ÀÌ ¶§¹®¿¡ ÀϺΠ±¹°¡¿¡¼­´Â °è¼Ó ¼±È£µÉ Àü¸ÁÀÔ´Ï´Ù.

È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀåÀº 1ȸ ÁÖ»çÀÇ Áö¼ÓÀûÀÎ µµÀÔ°ú ´Ù¸¥ ÀûÀÀ È®´ë¿¡ ÀÇÇØ °ßÀ뵃 Àü¸ÁÀÔ´Ï´Ù.

´ëü ¿ä¹ýÀÇ ÀÎÁöµµ¿Í Àαâ Áõ°¡´Â È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀå¿¡ Á¦ÇÑÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

À¯·´ HA ÁÖ»çÀÇ »óȯÀº Á¶»ç¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ±¹³» Á¦Á¶¾÷ü°¡ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, 2019³âºÎÅÍ 2033³â±îÁö ½ÃÀå »óȲ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ¿Í ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

¼¼°è

¿ä¾à

ÁÖ¿ä ¿ä¾à

ÁÖ¿ä º¸°í¼­ ¾÷µ¥ÀÌÆ®

¼¼°èÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀå

¹Ì±¹ÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀå

À¯·´ÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀå

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀå

ºê¶óÁúÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» Á¡¼ºº¸Ãæ ½ÃÀå

ºÎ·Ï

Á¶»ç ¹æ¹ý

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Favorable demographics, such as an aging population and rising osteoarthritis cases, increased patient awareness, improved physician training, effective marketing efforts by companies, and ongoing product innovation will contribute to the modest growth in the HA viscosupplementation market. Although alternative treatments are gaining traction, emerging clinical evidence supporting the efficacy of HA viscosupplementation in reducing pain associated with osteoarthritis will support HA viscosupplementation market growth. Furthermore, premium-priced 1-injection products will continue to become more popular over the forecast period due to their convenience, whereas 3 and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for HA viscosupplementation in the US, Europe, Asia Pacific, and Brazil from 2019 through 2033.

The HA viscosupplementation market will be driven by the continuous introduction of 1-injection and other indication expansion.

Rising awareness and popularity of alternative therapies will have a limiting impact on the HA viscosupplementation market.

Reimbursement for HA injections in Europe is facing scrutiny.

In the Asia Pacific region, domestic manufacturers have gained popularity.

Table of Contents

Global

Abstract

Executive Summary

Key Report Updates

Global Hyaluronic Acid Viscosupplementation Market

US Hyaluronic Acid Viscosupplementation Market

European Hyaluronic Acid Viscosupplementation Market

Asia Pacific Hyaluronic Acid Viscosupplementation Market

Brazilian Hyaluronic Acid Viscosupplementation Market

Appendix

Methodology

Tables and figures

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â